Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Pseudomonas Infections 1Neutropenia 1Gram-Positive Bacterial Infections 1Fever 1Febrile Neutropenia 1

Interventions

Carboplatin 314Paclitaxel 302Cisplatin 250Docetaxel 237pembrolizumab 230Gemcitabine 213Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 120Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 92Prednisone 91Oxaliplatin 89atezolizumab 73Leucovorin 71durvalumab 69130-nm albumin-bound paclitaxel 67Injections 64Lenalidomide 63Irinotecan 60Bortezomib 55Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × Vancomycin × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

NCT00035425 2009-12-01

Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

Pfizer

Phase 3 Completed
120 enrolled
Classical hematology

Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡